← Back to Search

PennPET Explorer Scanner Evaluation for Body Imaging

Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult participants, at least 18 years of age
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year.
Awards & highlights

Study Summary

This trial is testing a new kind of PET machine that can take pictures of a larger section of the body.

Who is the study for?
This trial is for adults over 18 who can consent to participate or have a representative to do so. It's suitable for those with cognitive impairment and healthy subjects interested in PET imaging research. People with serious health issues, psychological conditions, or mobility problems that could affect their safety or participation are not eligible.Check my eligibility
What is being tested?
The study is evaluating the PennPET Explorer Scanner, which is an investigational PET machine capable of imaging larger sections of the body at once compared to current clinical scanners. The goal is to gather data on how best to utilize this whole-body scanner.See study design
What are the potential side effects?
Potential side effects may include reactions related to the radioactive drug used during PET scanning such as discomfort at injection site, allergic reactions, and rare instances of radiation exposure-related risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I am 18 years old or older.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year.
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Image Performance of the LAFOV PennPET Explorer

Trial Design

1Treatment groups
Experimental Treatment
Group I: PennPET ExplorerExperimental Treatment1 Intervention
All subjects will be scanned in the CT scanner and then the scanner bed will be moved into position in the PennPET Explorer for initiation of the PET scan. For all PET scans a radioactive imaging drug is used. The radiotracer injection may be performed according to one of the following scenarios: As part of a clinical standard-of-care (SOC) PET/CT or PET/MRI scan (using an FDA-approved radiotracer; the PennPET Explorer cannot yet accommodate a study that requires a commercially available 510(k)-approved instrument for clinical results, subjects in this group will be scanned on both a commercial instrument (PET/CT or PET.MRI) and the PennPET Explorer), As part of another research study (using either an FDA-approved radiotracer or an investigational radiotracer), As a research injection designed specifically to utilize the PennPET Explorer (using an FDA-approved radiotracer).

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,879,783 Total Patients Enrolled

Media Library

Long AFOV PennPET Explorer Clinical Trial Eligibility Overview. Trial Name: NCT04617912 — N/A
Cognitive Impairment Research Study Groups: PennPET Explorer
Cognitive Impairment Clinical Trial 2023: Long AFOV PennPET Explorer Highlights & Side Effects. Trial Name: NCT04617912 — N/A
Long AFOV PennPET Explorer 2023 Treatment Timeline for Medical Study. Trial Name: NCT04617912 — N/A
Cognitive Impairment Patient Testimony for trial: Trial Name: NCT04617912 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current opportunities to become involved in this clinical trial?

"According to the available information on clinicaltrials.gov, this medical experiment is actively seeking participants since its initial posting in November of 2020 and recent update in March 2022."

Answered by AI

What is the ceiling of participants in this research endeavor?

"Correct. As of March 25th 2022, the clinicaltrial.gov website confirms that this research is actively recruiting participants since its initiation on November 12th 2020. The investigators aim to enroll 99 patients at a single site."

Answered by AI

Who else is applying?

What state do they live in?
New Jersey
How old are they?
18 - 65
What site did they apply to?
University of Pennsylvania
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?

Why did patients apply to this trial?

Interested in healthy trial. This looks like an interesting study.
PatientReceived 1 prior treatment
~30 spots leftby Nov 2025